Populations of pancreatic progenitor cells and methods of isolating and using same
A method of generating pancreatic progenitor cells is disclosed. The method comprises: (a) differentiating stem cells under conditions such that at least a portion of the cells express glucose transporter 2 (GLUT2) so as to generate GLUT2-expressing cells; and (b) enriching for the GLUT2-expressing cells so as to generate a population of GLUT2 enriched cells, wherein at least 80% of the population of GLUT2 enriched cells express GLUT2, thereby generating pancreatic progenitor cells. Isolated populations of cells generated according to the method, pharmaceutical compositions comprising same and uses thereof are also disclosed.
1. A method of generating GLUT2-expressing cells the method comprising:
(a) differentiating human stem cells under conditions such that at least a portion of said cells express glucose transporter 2 (GLUT2) on a membrane of said cells so as to generate GLUT2-expressing cells; and
(b) isolating from said cells resultant of step (a) GLUT2-expressing cells using an anti GLUT2 antibody which binds to said GLUT2 expressed on said membrane so as to generate a population of GLUT2 enriched cells, wherein at least 80% of said population of GLUT2 enriched cells express GLUT2, thereby generating GLUT2-expressing cells.
2. The method of claim 1 , wherein said isolating is effected by a fluorescence-activated cell sorter (FACS).
3. The method of claim 1 , wherein said human stem cells comprise human embryonic stem cells.
4. The method of claim 1 , wherein said stem cells comprise induced pluripotent stem cells.
5. The method of claim 1 , wherein said human stem cells comprise human pluripotent stem cells.
6. The method of claim 1 , wherein said differentiating said human stem cells is effected by generating embryoid bodies.
7. The method of claim 6 , wherein said embryoid bodies are 14 day old.
8. The method of claim 6 , wherein said embryoid bodies 14-25 day old.
9. The method of claim 6 , wherein said embryoid bodies are 14-19 day old.
10. The method of claim 1 , wherein said conditions comprise a glucose concentration of less than 5 mM.
11. The method of claim 1 , wherein said isolating is effected by a magnetic-activated cell sorting (MACS).
12. The method of claim 1 , further comprising:
(c) differentiating said population of GLUT2 enriched cells into insulin-producing cells.